Cargando…

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

Background: Percutaneous radiofrequency ablation (RFA) is one of the main treatments of small hepatocellular carcinoma (HCC). However, it remains unclear whether this local treatment can induce systemic immune variations. Methods: We conducted a prospective study in a tertiary center including conse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rochigneux, Philippe, Nault, Jean-Charles, Mallet, Françoise, Chretien, Anne-Sophie, Barget, Nathalie, Garcia, Alejandro J., Del Pozo, Lucie, Bourcier, Valérie, Blaise, Lorraine, Grando-Lemaire, Véronique, N’Kontchou, Gisèle, Nahon, Pierre, Seror, Olivier, Ziol, Marianne, Ganne-Carrié, Nathalie, Olive, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682367/ https://www.ncbi.nlm.nih.gov/pubmed/31413924 http://dx.doi.org/10.1080/2162402X.2019.1615818

Ejemplares similares

Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation
por: Gigante, Elia, et al.
Publicado: (2022)

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma
por: Mouhoubi, Nesrine, et al.
Publicado: (2022)

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2021)

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
por: Nahon, Pierre, et al.
Publicado: (2021)

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
por: Greten, Tim F, et al.
Publicado: (2010)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
por: Nahon, Pierre, et al.
Publicado: (2019)

Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma
por: Liu, Zhicheng, et al.
Publicado: (2017)

Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Roth, Gaël S., et al.
Publicado: (2021)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

Preclinical and post-treatment changes in the HCC-associated serum proteome
por: Ward, D G, et al.
Publicado: (2006)

Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
por: Roth, Gael, et al.
Publicado: (2022)

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
por: Ward, D G, et al.
Publicado: (2006)

Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
por: Buscail, Camille, et al.
Publicado: (2018)

New insights into the pathophysiology and clinical care of rare primary liver cancers
por: Gigante, Elia, et al.
Publicado: (2020)

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy
por: Wlosik, J., et al.
Publicado: (2022)

Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation
por: Hocquelet, Arnaud, et al.
Publicado: (2016)

Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022)
por: Sidali, Sabrina, et al.
Publicado: (2023)

Molecular classification of hepatocellular adenomas: impact on clinical practice
por: Védie, Anne-Laure, et al.
Publicado: (2018)

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
por: Amaddeo, Giuliana, et al.
Publicado: (2020)

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
por: Rousset-Rouviere, Sandrine, et al.
Publicado: (2021)

Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon
por: Ateudjieu, Jérôme, et al.
Publicado: (2013)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
por: Houessinon, Aline, et al.
Publicado: (2016)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma
por: Usachov, Valentyn, et al.
Publicado: (2012)

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
por: Gigante, Elia, et al.
Publicado: (2022)

Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2020)

Implementing advanced practice nursing in France: A country‐wide survey 2 years after its introduction
por: Devictor, Julie, et al.
Publicado: (2022)

Role of psychomotricity in the management of body image disorders in schizophrenia: a case report
por: Eyoum, Christian, et al.
Publicado: (2021)

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015)

RE: Should We Use a Monopolar or Bipolar Mode for Performing No-Touch Radiofrequency Ablation of Liver Tumors? Clinical Practice Might have Already Resolved the Matter Once and for All
por: Seror, Olivier, et al.
Publicado: (2017)

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
por: Planes-Laine, Gabrielle, et al.
Publicado: (2019)

Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis
por: Rakhila, Halima, et al.
Publicado: (2015)

Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
por: Faure, Marjorie, et al.
Publicado: (2018)

Impact of Extended Use of Ablation Techniques in Cirrhotic Patients with Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
por: Ramtohul, Toulsie, et al.
Publicado: (2022)

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
por: Chretien, Anne-Sophie, et al.
Publicado: (2014)

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review
por: Rochigneux, Philippe, et al.
Publicado: (2020)

Effect of COVID-19 on immunization coverage of children aged 0-11 months in the center region of Cameroon
por: METCHEHE, LOÏC DORIA DJOMMO, et al.
Publicado: (2023)

Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study
por: Chanez, Brice, et al.
Publicado: (2021)

Impact of patient ancestry on heterogeneity of Sjögren’s disease
por: Beydon, Maxime, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8oo2h751o9pug3tt4om4qv3n5